{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T05:43:46Z","timestamp":1791265426673,"version":"4.1.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,7]],"date-time":"2016-10-07T00:00:00Z","timestamp":1475798400000},"content-version":"vor","delay-in-days":1071,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1038\/mt.2013.171","type":"journal-article","created":{"date-parts":[[2013,8,5]],"date-time":"2013-08-05T11:15:01Z","timestamp":1375701301000},"page":"2019-2031","source":"Crossref","is-referenced-by-count":30,"title":["Measles Virus Entry Through the Signaling Lymphocyte Activation Molecule Governs Efficacy of Mantle Cell Lymphoma Radiovirotherapy"],"prefix":"10.1016","volume":"21","author":[{"given":"Tanner S","family":"Miest","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Frenzke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Cattaneo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/mt.2013.171_bib1","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1038\/nbt.2287","article-title":"Oncolytic virotherapy","volume":"30","author":"Russell","year":"2012","journal-title":"Nat Biotechnol"},{"key":"10.1038\/mt.2013.171_bib2","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/nrmicro1927","article-title":"Reprogrammed viruses as cancer therapeutics: targeted, armed and shielded","volume":"6","author":"Cattaneo","year":"2008","journal-title":"Nat Rev Microbiol"},{"key":"10.1038\/mt.2013.171_bib3","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/379458a0","article-title":"Cloning and characterization of the thyroid iodide transporter","volume":"379","author":"Dai","year":"1996","journal-title":"Nature"},{"key":"10.1038\/mt.2013.171_bib4","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2174\/156652312799789235","article-title":"The sodium iodide symporter (NIS) as an imaging reporter for gene, viral, and cell-based therapies","volume":"12","author":"Penheiter","year":"2012","journal-title":"Curr Gene Ther"},{"key":"10.1038\/mt.2013.171_bib5","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1182\/blood-2003-07-2233","article-title":"Image-guided radiovirotherapy for multiple myeloma using a recombinant measles virus expressing the thyroidal sodium iodide symporter","volume":"103","author":"Dingli","year":"2004","journal-title":"Blood"},{"key":"10.1038\/mt.2013.171_bib6","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.critrevonc.2011.05.001","article-title":"Mantle cell lymphoma","volume":"82","author":"Cortelazzo","year":"2012","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1038\/mt.2013.171_bib7","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.critrevonc.2010.09.003","article-title":"Mantle cell lymphoma: the promise of new treatment options","volume":"80","author":"Goy","year":"2011","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1038\/mt.2013.171_bib8","doi-asserted-by":"crossref","first-page":"7905","DOI":"10.1038\/sj.onc.1206826","article-title":"Multiple molecular mechanisms contribute to radiation sensitivity in mantle cell lymphoma","volume":"22","author":"M'kacher","year":"2003","journal-title":"Oncogene"},{"key":"10.1038\/mt.2013.171_bib9","doi-asserted-by":"crossref","first-page":"5213","DOI":"10.1200\/JCO.2009.21.8545","article-title":"Phase II study of yttrium-90-ibritumomab tiuxetan in patients with relapsed or refractory mantle cell lymphoma","volume":"27","author":"Wang","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1038\/mt.2013.171_bib10","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1099\/vir.0.82221-0","article-title":"Measles virus: cellular receptors, tropism and pathogenesis","volume":"87","author":"Yanagi","year":"2006","journal-title":"J Gen Virol"},{"key":"10.1038\/mt.2013.171_bib11","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1038\/35022579","article-title":"SLAM (CDw150) is a cellular receptor for measles virus","volume":"406","author":"Tatsuo","year":"2000","journal-title":"Nature"},{"key":"10.1038\/mt.2013.171_bib12","doi-asserted-by":"crossref","first-page":"e178","DOI":"10.1371\/journal.ppat.0030178","article-title":"Predominant infection of CD150+ lymphocytes and dendritic cells during measles virus infection of macaques","volume":"3","author":"de Swart","year":"2007","journal-title":"PLoS Pathog"},{"key":"10.1038\/mt.2013.171_bib13","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0140-6736(71)92086-1","article-title":"Regression of Burkitt\u2019s lymphoma in association with measles infection","volume":"2","author":"Bluming","year":"1971","journal-title":"Lancet"},{"key":"10.1038\/mt.2013.171_bib14","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S0140-6736(71)91186-X","article-title":"Hodgkin\u2019s disease: remissions after measles","volume":"1","author":"Zygiert","year":"1971","journal-title":"Lancet"},{"key":"10.1038\/mt.2013.171_bib15","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/0092-8674(93)80071-L","article-title":"The human CD46 molecule is a receptor for measles virus (Edmonston strain)","volume":"75","author":"D\u00f6rig","year":"1993","journal-title":"Cell"},{"key":"10.1038\/mt.2013.171_bib16","doi-asserted-by":"crossref","first-page":"6025","DOI":"10.1128\/JVI.67.10.6025-6032.1993","article-title":"Human membrane cofactor protein (CD46) acts as a cellular receptor for measles virus","volume":"67","author":"Naniche","year":"1993","journal-title":"J Virol"},{"key":"10.1038\/mt.2013.171_bib17","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1158\/0008-5472.CAN-09-2762","article-title":"Phase I trial of intraperitoneal administration of an oncolytic measles virus strain engineered to express carcinoembryonic antigen for recurrent ovarian cancer","volume":"70","author":"Galanis","year":"2010","journal-title":"Cancer Res"},{"key":"10.1038\/mt.2013.171_bib18","doi-asserted-by":"crossref","first-page":"4919","DOI":"10.1158\/0008-5472.CAN-04-0884","article-title":"High CD46 receptor density determines preferential killing of tumor cells by oncolytic measles virus","volume":"64","author":"Anderson","year":"2004","journal-title":"Cancer Res"},{"key":"10.1038\/mt.2013.171_bib19","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.exphem.2006.03.002","article-title":"Oncolytic measles virus targets high CD46 expression on multiple myeloma cells","volume":"34","author":"Ong","year":"2006","journal-title":"Exp Hematol"},{"key":"10.1038\/mt.2013.171_bib20","doi-asserted-by":"crossref","first-page":"4714","DOI":"10.1128\/JVI.02633-09","article-title":"In vivo tropism of attenuated and pathogenic measles virus expressing green fluorescent protein in macaques","volume":"84","author":"de Vries","year":"2010","journal-title":"J Virol"},{"key":"10.1038\/mt.2013.171_bib21","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.1128\/JVI.06517-11","article-title":"Wild-type measles virus with the hemagglutinin protein of the Edmonston vaccine strain retains wild-type tropism in macaques","volume":"86","author":"Takeuchi","year":"2012","journal-title":"J Virol"},{"key":"10.1038\/mt.2013.171_bib22","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1038\/gt.2010.103","article-title":"Mantle cell lymphoma salvage regimen: synergy between a reprogrammed oncolytic virus and two chemotherapeutics","volume":"17","author":"Ungerechts","year":"2010","journal-title":"Gene Ther"},{"key":"10.1038\/mt.2013.171_bib23","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/gt.2010.150","article-title":"CD20-targeted measles virus shows high oncolytic specificity in clinical samples from lymphoma patients independent of prior rituximab therapy","volume":"18","author":"Yaiw","year":"2011","journal-title":"Gene Ther"},{"key":"10.1038\/mt.2013.171_bib24","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.virol.2006.09.049","article-title":"Tyrosine 110 in the measles virus phosphoprotein is required to block STAT1 phosphorylation","volume":"360","author":"Devaux","year":"2007","journal-title":"Virology"},{"key":"10.1038\/mt.2013.171_bib25","doi-asserted-by":"crossref","first-page":"7252","DOI":"10.1128\/JVI.00153-09","article-title":"A shared interface mediates paramyxovirus interference with antiviral RNA helicases MDA5 and LGP2","volume":"83","author":"Parisien","year":"2009","journal-title":"J Virol"},{"key":"10.1038\/mt.2013.171_bib26","doi-asserted-by":"crossref","first-page":"10597","DOI":"10.1128\/JVI.00923-07","article-title":"A vectored measles virus induces hepatitis B surface antigen antibodies while protecting macaques against measles virus challenge","volume":"81","author":"del Valle","year":"2007","journal-title":"J Virol"},{"key":"10.1038\/mt.2013.171_bib27","doi-asserted-by":"crossref","first-page":"5773","DOI":"10.1002\/j.1460-2075.1995.tb00266.x","article-title":"Rescue of measles viruses from cloned DNA","volume":"14","author":"Radecke","year":"1995","journal-title":"EMBO J"},{"key":"10.1038\/mt.2013.171_bib28","doi-asserted-by":"crossref","first-page":"2991","DOI":"10.1099\/vir.0.80308-0","article-title":"Dissection of measles virus V protein in relation to its ability to block alpha\/beta interferon signal transduction","volume":"85","author":"Ohno","year":"2004","journal-title":"J Gen Virol"},{"key":"10.1038\/mt.2013.171_bib29","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/sj.mt.6300076","article-title":"Engineering oncolytic measles virus to circumvent the intracellular innate immune response","volume":"15","author":"Haralambieva","year":"2007","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2013.171_bib30","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/bjc.1988.54","article-title":"Validation of the fluorescent dye Hoechst 33342 as a vascular space marker in tumours","volume":"57","author":"Smith","year":"1988","journal-title":"Br J Cancer"},{"key":"10.1038\/mt.2013.171_bib31","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1038\/sj.mt.6300215","article-title":"Targeted inflammation during oncolytic virus therapy severely compromises tumor blood flow","volume":"15","author":"Breitbach","year":"2007","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2013.171_bib32","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/clpt.2010.211","article-title":"Therapeutic potential of oncolytic measles virus: promises and challenges","volume":"88","author":"Galanis","year":"2010","journal-title":"Clin Pharmacol Ther"},{"key":"10.1038\/mt.2013.171_bib33","doi-asserted-by":"crossref","first-page":"e1002240","DOI":"10.1371\/journal.ppat.1002240","article-title":"Tumor cell marker PVRL4 (nectin 4) is an epithelial cell receptor for measles virus","volume":"7","author":"Noyce","year":"2011","journal-title":"PLoS Pathog"},{"key":"10.1038\/mt.2013.171_bib34","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/nature10639","article-title":"Adherens junction protein nectin-4 is the epithelial receptor for measles virus","volume":"480","author":"M\u00fchlebach","year":"2011","journal-title":"Nature"},{"key":"10.1038\/mt.2013.171_bib35","doi-asserted-by":"crossref","first-page":"19543","DOI":"10.1074\/jbc.M410943200","article-title":"Nectin-4, a new serological breast cancer marker, is a substrate for tumor necrosis factor-alpha-converting enzyme (TACE)\/ADAM-17","volume":"280","author":"Fabre-Lafay","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1038\/mt.2013.171_bib36","doi-asserted-by":"crossref","first-page":"6694","DOI":"10.1158\/0008-5472.CAN-09-0016","article-title":"Identification of nectin-4 oncoprotein as a diagnostic and therapeutic target for lung cancer","volume":"69","author":"Takano","year":"2009","journal-title":"Cancer Res"},{"key":"10.1038\/mt.2013.171_bib37","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1309\/AJCPGXK0FR4MHIHB","article-title":"Nectin 4 overexpression in ovarian cancer tissues and serum: potential role as a serum biomarker","volume":"134","author":"Derycke","year":"2010","journal-title":"Am J Clin Pathol"},{"key":"10.1038\/mt.2013.171_bib38","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1073\/pnas.88.4.1394","article-title":"scid mutation in mice confers hypersensitivity to ionizing radiation and a deficiency in DNA double-strand break repair","volume":"88","author":"Biedermann","year":"1991","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mt.2013.171_bib39","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1182\/blood-2009-05-220798","article-title":"Efficient and stable transduction of resting B lymphocytes and primary chronic lymphocyte leukemia cells using measles virus gp displaying lentiviral vectors","volume":"114","author":"Frecha","year":"2009","journal-title":"Blood"},{"key":"10.1038\/mt.2013.171_bib40","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1056\/NEJMra0807082","article-title":"Aggressive lymphomas","volume":"362","author":"Lenz","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1038\/mt.2013.171_bib41","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1111\/j.1600-6143.2011.03499.x","article-title":"Epstein-Barr Virus-related post-transplant lymphoproliferative disorders: pathogenetic insights for targeted therapy","volume":"11","author":"Nourse","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1038\/mt.2013.171_bib42","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1182\/blood.V99.3.957","article-title":"Molecular dissection of the signaling and costimulatory functions of CD150 (SLAM): CD150\/SAP binding and CD150-mediated costimulation","volume":"99","author":"Howie","year":"2002","journal-title":"Blood"},{"key":"10.1038\/mt.2013.171_bib43","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.2967\/jnumed.112.105056","article-title":"A vaccinia virus encoding the human sodium iodide symporter facilitates long-term image monitoring of virotherapy and targeted radiotherapy of pancreatic cancer","volume":"53","author":"Haddad","year":"2012","journal-title":"J Nucl Med"},{"key":"10.1038\/mt.2013.171_bib44","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/sj.leu.2400555","article-title":"Potential role for concurrent abnormalities of the cyclin D1, p16CDKN2 and p15CDKN2B genes in certain B cell non-Hodgkin\u2019s lymphomas. Functional studies in a cell line (Granta 519)","volume":"11","author":"Jadayel","year":"1997","journal-title":"Leukemia"},{"key":"10.1038\/mt.2013.171_bib45","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.cancergencyto.2004.01.006","article-title":"Molecular cytogenetic characterization of the mantle cell lymphoma cell line GRANTA-519","volume":"153","author":"Rudolph","year":"2004","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1038\/mt.2013.171_bib46","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1007\/BF01863914","article-title":"Beitrag zur kollektiven Behandlung pharmakologischer Reihenversuche","volume":"162","author":"K\u00e4rber","year":"1931","journal-title":"Naunyn-Schmied Arch Pharmacol"},{"key":"10.1038\/mt.2013.171_bib47","series-title":"Bioassays, 2nd edn","first-page":"65","article-title":"Spearman-Karber method","author":"Hubert","year":"1984"},{"key":"10.1038\/mt.2013.171_bib48","first-page":"2957","article-title":"Development of monoclonal antibodies against the human sodium iodide symporter: immunohistochemical characterization of this protein in thyroid cells","volume":"84","author":"Castro","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1038\/mt.2013.171_bib49","first-page":"7840","article-title":"Probasin promoter (ARR(2)PB)-driven, prostate-specific expression of the human sodium iodide symporter (h-NIS) for targeted radioiodine therapy of prostate cancer","volume":"63","author":"Kakinuma","year":"2003","journal-title":"Cancer Res"},{"key":"10.1038\/mt.2013.171_bib50","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1038\/mt.2011.92","article-title":"Envelope-chimeric entry-targeted measles virus escapes neutralization and achieves oncolysis","volume":"19","author":"Miest","year":"2011","journal-title":"Mol Ther"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152500161630925X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152500161630925X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T12:14:25Z","timestamp":1596284065000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152500161630925X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":50,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S152500161630925X"],"URL":"https:\/\/doi.org\/10.1038\/mt.2013.171","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]}}}